Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Rahil Jummani
Aripiprazole in Children and Adolescents With Tourette's Disorder: An Open-Label Safety and Tolerability Study
Journal of Child and Adolescent Psychopharmacology
Mental Health
Child Health
Pharmacology
Perinatology
Psychiatry
Pediatrics
Related publications
Safety and Tolerability of Desvenlafaxine in Children and Adolescents With Major Depressive Disorder
Journal of Child and Adolescent Psychopharmacology
Mental Health
Child Health
Pharmacology
Perinatology
Psychiatry
Pediatrics
Relative Efficacy of Haloperidol and Pimozide in Children and Adolescents With Tourette's Disorder
American Journal of Psychiatry
Psychiatry
Mental Health
Erratum To: Safety and Tolerability of Levomilnacipran ER in Major Depressive Disorder: Results From an Open-Label, 48-Week Extension Study
Clinical Drug Investigation
Medicine
Pharmacology
Efficacy, Safety and Tolerability of Escitalopram in Doses Up to 50 Mg in Major Depressive Disorder (MDD): An Open-Label, Pilot Study
BMC Psychiatry
Psychiatry
Mental Health
Aripiprazole in Pervasive Developmental Disorder Not Otherwise Specified and Asperger's Disorder: A 14-Week, Prospective, Open-Label Study
Journal of Child and Adolescent Psychopharmacology
Mental Health
Child Health
Pharmacology
Perinatology
Psychiatry
Pediatrics
Safety and Tolerability of Adjunctive Lacosamide in a Pediatric Population With Focal Seizures-An Open-Label Trial
Seizure : the journal of the British Epilepsy Association
Medicine
Neurology
A Phase 3, Multicenter, Open-Label, 12-Month Extension Safety and Tolerability Trial of Lisdexamfetamine Dimesylate in Adults With Binge Eating Disorder
Journal of Clinical Psychopharmacology
Psychiatry
Mental Health
Pharmacology
Efficacy and Tolerability of Different Interventions in Children and Adolescents With Attention Deficit Hyperactivity Disorder
Frontiers in Psychiatry
Psychiatry
Mental Health
Tolerability and Safety of Novel Half Milliliter Formulation of Glatiramer Acetate for Subcutaneous Injection: An Open-Label, Multicenter, Randomized Comparative Study
Journal of Neurology
Neurology
